[Analysis of Clinical Characteristics and Laboratory Indicators in Patients with Solid Malignant Tumor-Associated Venous Thromboembolism].

Objective: To analyze the clinical features and laboratory indicators in patients with solid malignant tumor-associated venous thromboembolism (Ta-VTE), and to study the risk factors for Ta-VTE.

Methods: The hospitalized patients with VTE in Guizhou Provincial People's Hospital from January to December 2020 were enrolled, and they were divided into Ta-VTE group and pure VTE group based on the presence or absence of solid malignant tumor. The differences in clinical data and laboratory indicators between the two groups were analyzed, and the indicators with significant differences were included in logistic regression model to analyze the risk factors of Ta-VTE.

Results: A total of 288 patients with VTE were included in this study, including 64 cases in Ta-VTE group and 224 cases in pure VTE group, respectively. There were significant differences in the following indexes between the two groups, including the hospitalization time (14.20±15.29 d 10.05±6.90 d, =3.112, =0.002), pain (35.94% 65.18%, =17.554, =0.000), recent surgery (75.00% 37.50%, =28.196, =0.000), D-dimer [2.8 (0.92, 7.55) μg/ml 5.69 (2.25, 13.91) μg/ml, =-2.710, =0.007], PLR[198.59 (139.54, 312.16) 149.76 (114.08, 233.66), =-2.924, =0.003] and TBIL[10.90 (7.63, 15.68) μmol/L 12.90 (9.33, 18.28) μmol/L, =-2.066, =0.039]. There was no significant difference in the other indicators ( >0.05). The result of multivariate logistic regression analysis showed that elevated PLR ( =1.003, 95% : 1.000-1.006, =0.027), recent surgery ( =4.312, 95% : 2.093-8.885, =0.000) and prolonged hospitalization ( =1.037, 95% : 1.002-1.074, =0.038）were independent risk factors for Ta-VTE. However, pain ( =0.274, 95% : 0.133-0.564, =0.000) was a protective factor.

Conclusion: Elevated PLR level, recent surgery and prolonged hospital stay are independent risk factors for Ta-VTE patients, and rational use of these indicators is helpful for the clinical diagnosis and treatment of Ta-VTE patients.